Keynote I: Overcoming Structural Barriers to Diverse Representation and Clinical Trials

Dr. Carmen Guerra presents on the persistent racial and ethnic disparities that exist in patient access to clinical trials in head and neck oncology. She describes the extent of the representation gap and provide examples of successful programs in place that are actively improving the status quo. Participants will leave able to more optimally collect and report on data on race and ethnicity, and with ideas to engage with their local communities to work towards the FDA’s diversity action plan with respect to head and neck oncology.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Improve the accuracy of race and ethnicity data collection in clinical trials.
  • Approach work with communities to partner on clinical trial awareness and recruitment with humility and mutual respect.
  • Use tools described in the lecture to work with your home institutions to operationalize aspects of the FDA’s diversity action plan.
Course summary
Available credit: 
  • 0.75 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 0.75 Certificate of Attendance
    This activity was designated for 0.75 AMA PRA Category 1 Credit™.
Course opens: 
03/11/2024
Course expires: 
03/10/2026
Cost:
$0.00
Part of: 
2024 Multidisciplinary Head and Neck Cancers Symposium onDemand
Rating: 
0

Kelley Malloy, MD, is employed by the University of Michigan and has no financial relationships with a commercial interest.

Carmen Guerra, MD, MSCR, FACP, is employed by University of Pennsylvania and receives research funding by Genentech and has stock with BEAM, CRISPER, Editas, Intellia.

All relevant relationships have been mitigated.

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

Available Credit

  • 0.75 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 0.75 Certificate of Attendance
    This activity was designated for 0.75 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.